Chemokine Receptor CXCR4 Is a Novel Marker for the Progression of Cutaneous Malignant Melanomas-Reference-Cited by-同舟云学术

Chemokine Receptor CXCR4 Is a Novel Marker for the Progression of Cutaneous Malignant Melanomas

Published:2012 Issue:5 Volume:45 Page:293-299
ISSN:0044-5991
Container-title:ACTA HISTOCHEMICA ET CYTOCHEMICA
language:en
Short-container-title:Acta Histochem. Cytochem

Author:

Toyozawa Seiko¹¹,Kaminaka Chikako¹²¹²,Furukawa Fukumi¹¹,Nakamura Yasushi³³,Matsunaka Hiroshi¹¹,Yamamoto Yuki¹¹²

Affiliation:

1. Department of Dermatology, Wakayama Medical University

2. Department of Cosmetic Dermatology and Photomedicine, Wakayama Medical University

3. Department of Clinical Laboratory Medicine, Wakayama Medical University

Publisher

Japan Society of Histochemistry & Cytochemistry

Subject

Cell Biology,Histology,Physiology,Biochemistry,Pathology and Forensic Medicine

Link

https://www.jstage.jst.go.jp/article/ahc/45/5/45_12004/_pdf

Reference22 articles.

1. 1. Bartolomé, R. A., Gálvez, B. G., Longo, N., Baleux, F., Van Muijen, G. N., Sánchez-Mateos, P., Arroyo, A. G. and Teixidó, J. (2004) Stromal dell-derived factor-1α promotes melanoma cell invasion across basement membranes involving stimulation of membrane-type 1 matrix metalloproteinase and Rho GTPase activities. Cancer Res. 64; 2534-2543.

2. 2. Bleul, C. C., Farzan, M., Choe, H., Parolin, C., Clark-Lewis, I., Sodroski, J. and Springer, T. A. (1996) The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382; 829-833.

3. 3. Ding, Y., Shimada, Y., Maeda, M., Kawabe, A., Kaganoi, J., Komoto, I., Hashimoto, Y., Miyake, M., Hashida, H. and Imamura, M. (2003) Association of CC chemokine 7 with lymph node metastasis of esophageal squamous cell carcinoma. Clin. Cancer Res. 9; 3406-3412.

4. 4. Kaminaka, C., Toyozawa, S., Yonei, N., Kunimoto, K., Furukawa, F. and Yamamoto, Y. (2011) Phenol peels for the treatment of actinic keratosis and Bowen’s disease: correlation with chemokine receptors expression. Skin Cancer 26; 327-332 (Abstract in English).

5. 5. Kawada, K., Sonoshita, M., Sakashita, H., Takabayashi, A., Yamaoka, Y., Manabe, T., Inaba, K., Minato, N., Oshima, M. and Taketo, M. M. (2004) Pivotal rale of CXCR3 in melanoma cell metastasis to lymph nodes. Cancer Res. 64; 4010-4017.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Interplay of RUNX2 and CXCR4 in Melanoma Progression;Cells;2024-02-27

2. Mavorixafor, an Orally Bioavailable CXCR4 Antagonist, Increases Immune Cell Infiltration and Inflammatory Status of Tumor Microenvironment in Patients with Melanoma;Cancer Research Communications;2022-08-31

3. Molecular biology exploration and targeted therapy strategy of Ameloblastoma;Archives of Oral Biology;2022-08

4. Overexpression of chemokine receptor CXCR4 predicts lymph node metastatic risk in patients with melanoma: A systematic review and meta-analysis;Cytokine;2021-12

5. Chemokine CXCR-4 and cyclooxygenase-2 in the pathogenesis of pterygium;TURKISH JOURNAL OF MEDICAL SCIENCES;2017